Drug Targeting and Design
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Self-Assembled Amphiphilic Copolymers in Drug Delivery, 2nd Edition (Deadline: 15 October 2024)
- Nucleic-Acid-Based Strategies and Nanotechnology Applications for Targeted Therapy (Deadline: 20 October 2024)
- The State-of-the-art in Improving the Antitumor Efficacy of Platinum Drugs (Deadline: 20 October 2024)
- The Role of Free Radicals and Antioxidants in Drug Activation and Effectiveness in Different Biological Systems (Deadline: 20 October 2024)
- Drugs and Drug Delivery for Diabetes Mellitus Treatment, 2nd Edition (Deadline: 30 October 2024)
- New Discoveries in Drug Targets and Delivery for Alzheimer’s Disease (Deadline: 30 October 2024)
- Cancer Therapy Resistance: Choosing Kinase Inhibitors, 2nd Edition (Deadline: 30 October 2024)
- Advances in Anticancer Agent, 2nd Edition (Deadline: 31 October 2024)
- Natural Products for Anticancer Application (Deadline: 31 October 2024)
- New and Emerging Targeted Topical and Systemic Drugs for Immunemediated Cutaneous Diseases (Deadline: 31 October 2024)
- Photodynamic Therapy: Recent Progress and Development (Deadline: 31 October 2024)
- Advances in Drug Delivery Systems for Transmucosal Routes Applied in the Treatment of Infectious and Chronic Degenerative Diseases (Deadline: 15 November 2024)
- Ultrasound Assisted in Tumor Immunotherapy (Deadline: 20 November 2024)
- Computer-Aided Development: Recent Advances and Expectations (Deadline: 20 November 2024)
- Peptide–Drug Conjugates for Targeted Delivery (Deadline: 20 November 2024)
- Metallodrugs in Cancer Therapy: The Newest Candidates in the Field, 2nd Edition (Deadline: 20 November 2024)
- Novel Therapies Based on Autophagy Modulation: Targets, Mechanisms, and Delivery Approaches (Deadline: 20 November 2024)
- Advances in Antiparasitic Agents (Deadline: 25 November 2024)
- Novel Therapeutic Approaches for the Treatment of Neurodegenerative Diseases (Deadline: 30 November 2024)
- Cutting-Edge Liposome Innovations for Precision Delivery and Cancer Treatment (Deadline: 30 November 2024)
- Novel Drugs, Targets and Therapies Against Infectious Diseases (Deadline: 30 November 2024)
- New Platform for Tuberculosis Treatment (Deadline: 30 November 2024)
- Natural Pharmaceuticals Focused on Anti-inflammatory Activities (Deadline: 30 November 2024)
- Applications of Stable Nuclide and Radionuclides in the Area of Pharmacokinetic Process Control and Targeted Drug Therapy (Deadline: 30 November 2024)
- Current and Future Cancer Chemoprevention Strategies, 2nd Edition (Deadline: 10 December 2024)
- Pharmaceutical Applications of Plant Extracts, 2nd Edition (Deadline: 10 December 2024)
- Pharmaceutical Applications of Metal Complexes and Derived Materials (Deadline: 20 December 2024)
- Next-Generation Antibody-Drug Conjugates (ADCs) (Deadline: 20 December 2024)
- Studies on the Cytotoxicity and Antimicrobial Effects of Synthetic and Natural Compounds (Deadline: 20 December 2024)
- State of the Art of Membrane Active Peptides, 2nd Edition (Deadline: 30 December 2024)
- In Vitro and In Vivo Studies of Natural Antimicrobial Peptides as Promising Therapeutic Agents (Deadline: 31 December 2024)
- Novel Pharmaceuticals Development and Delivery Systems for the Treatment of Parasitic Diseases, 2nd Edition (Deadline: 31 December 2024)
- Combination Therapy Approaches for Cancer Treatment (Deadline: 31 December 2024)
- Alternative Model-Based Translational Drug Development (Deadline: 31 December 2024)
- Emerging Pharmaceutical Strategies against Infectious Diseases (Deadline: 31 December 2024)
- Prodrugs and Molecular Hybrids as Innovative Strategies in Medicinal Chemistry (Deadline: 31 December 2024)
- Theranostic Radiopharmaceuticals: Current Status and Perspectives (Deadline: 31 December 2024)
- Recent Advances in Natural Product Drugs, 2nd Edition (Deadline: 31 December 2024)
- Where Are We Now and Where Is Antimicrobial Therapy Headed? (Deadline: 31 December 2024)
- Drug Targeting for CNS Disease, 2nd Edition (Deadline: 10 January 2025)
- Targeting Protein Aggregation and Degradation in Age-Related Diseases (Deadline: 20 January 2025)
- Application Prospect of Hydrogels in the Treatment of Osteochondral Lesions (Deadline: 20 January 2025)
- Drug Repurposing and Delivery Systems for Immunotherapy (Deadline: 20 January 2025)
- Targeted Immune Modulation Strategies for Cancer, Infectious and Autoimmune Diseases (Deadline: 31 January 2025)
- Small-Molecule Inhibitors for Novel Therapeutics (Deadline: 31 January 2025)
- Multi-Target Ligands Design and Targeted Drug Delivery (Deadline: 31 January 2025)
- Serpins: Therapeutic Targets for Various Diseases (Deadline: 31 January 2025)
- Research on the Design of New Metal-Based Antitumor Drugs (Deadline: 31 January 2025)
- Advances in Antileishmania Drug Agent (Deadline: 10 February 2025)
- Biomaterials and Agents: Pharmaceutical and Biomedical Applications in Dental Research, 2nd Edition (Deadline: 10 February 2025)
- Progress in Photoactive Biomaterial-Based Synergistic Combination Phototherapy (Deadline: 20 February 2025)
- Smart Radiotherapy Biomaterials for Cancer Therapy and Imaging (Deadline: 20 February 2025)
- Plant Extracts and Their Biomedical Applications (Deadline: 20 February 2025)
- Research on Radiotracers and Novel Radiopharmaceuticals for Cancer Therapy and Diagnosis (Deadline: 20 February 2025)
- Antiviral and Antibacterial: Focus on Novel Therapeutic Agents and Drug Delivery Systems (Deadline: 28 February 2025)
- Advanced Nanopharmaceuticals for Anticancer Therapy (Deadline: 28 February 2025)
- Membrane Transport and Drug Permeation (Deadline: 28 February 2025)
- Research on Porphyrin Compounds Used in Photodynamic Anticancer and Antimicrobial Therapy (Deadline: 28 February 2025)
- New Insights into Targeted Therapy of Solid Tumors with Polymeric Nanoparticles (Deadline: 28 February 2025)
- Natural Products in Photodynamic Therapy (Deadline: 20 March 2025)
- Therapeutic Approaches for Wound-Associated Skin Diseases (Deadline: 31 March 2025)
- Natural and Synthetic Compounds in Pharmaceutical Formulations and Drug Delivery Systems (Deadline: 31 March 2025)
- Recent Advances in Therapeutic Strategies for the Treatment of Pediatric Diseases (Deadline: 31 March 2025)
- Recent Advances in Hepatic-Targeted Drug Delivery Systems (Deadline: 31 March 2025)
- Brain Tumors Treatment: Current and Future Challenges from Drug Formulations to Delivery Methods (Deadline: 31 March 2025)
- Novel Approaches in the Search for Active Compounds in Drug Discovery and Development (Deadline: 1 April 2025)
- Natural Products and Extracts Important for Skin Health and Diseases (Deadline: 10 April 2025)
- Innovative Drug Delivery Systems for Enhanced Therapeutic Efficacy in Cancers, Liver Disease and Psoriasis (Deadline: 20 April 2025)